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Urinary biomarkers in autosomal
dominant polycystic kidney
disease: is there no prognostic
value?
To the Editor: We read with interest the article by Parikh
et al, in which they showed that levels of neutrophil
gelatinase-associated lipocalin (NGAL) and interleukin (IL)-
18 did not correlate with changes in kidney volume or
estimated glomerular ﬁltration rate (eGFR) during follow-up
in autosomal dominant polycystic kidney disease (ADPKD)
patients relatively early in their disease.1 Therefore, it was
suggested that urinary biomarkers of kidney injury have no
clinical prognostic utility.
Recently, we measured several biomarkers (glomerular,
tubular, and inﬂammatory) in urine samples (stored for 0.7
years at80 1C) of 102 ADPKD patients and found in a cross-
sectional study signiﬁcant associations between several urinary
biomarkers, including NGAL, and measures of ADPKD
severity.2 After having read the publication by Parikh et al,
we investigated the association of these markers with decline
in eGFR (Chronic Kidney Disease Epidemiology Collaboration)
in patients whose follow-up data were available without experi-
mental intervention (N¼ 46, age 40±14 years, 48% male,
baseline eGFR 73±37ml/min per 1.73 m2, eGFR change
during 2.6 years follow-up: 2.6±3.2ml/min per 1.73 m2/year).
We found signiﬁcant inverse associations between baseline
urinary biomarker excretion of albumin, IgG, KIM-1, and
MCP-1 and change in eGFR during follow-up (Table 1).
These associations remained signiﬁcant after adjustment for
age, gender, and baseline eGFR. Similar to Parikh et al, we
found no signiﬁcant association between NGAL and change
in eGFR, neither crude (P¼ 0.07) nor adjusted for age, sex, and
baseline eGFR (P¼ 0.47). Urinary IL-18 was not measured.
Importantly, we have previously shown that frozen storage
decreases the measured concentration of urinary biomarkers,
such as NGAL, and induces more variability, especially after
longer storage.3 The decline or increased variability in marker
concentration that is induced by frozen storage can therefore
reduce the association that, in reality, is present. We have
shown this latter phenomenon for urinary albumin concen-
tration in non-ADPKD subjects.4
Given these ﬁndings, we caution against a too skeptical
view toward the utility of urinary biomarkers to predict
disease progression in ADPKD. Our data indicate that some
of these markers may be useful. More research investigating
their prognostic value in ADPKD is deﬁnitely needed.
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Reappraisal of melamine exposure
and adult calcium urolithiasis
To the Editor: In reference to Lopez and Quereda’s comments
to our recent article and questions about source of low-dose
melamine exposure and change in incidence in urolithiasis
in adults in Taiwan,1,2 since the melamine-tainted formula
incident in China in 2008, melamine has been detected in a
few daily food products such as eggs, wheat gluten, and meats.
Our recent study found that some melamine could migrate
from daily-used melamine-made tableware even at room
Table 1 | Association between slope of eGFR (CKD-EPI) and
log-transformed urinary biomarker excretion
Crude
Adjusted for age,
gender, and baseline
eGFR
Std. B P-value Std. B P-value
Albumin (mg/24 h) 0.542 o0.001 0.474 0.005
IgG (mg/24h) 0.419 0.004 0.310 0.044
KIM-1 (mg/24 h) 0.347 0.018 0.447 0.001
MCP-1 (mg/24 h) 0.483 0.001 0.390 0.006
Abbreviations: CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; eGFR,
estimated glomerular filtration rate; IgG, Imunoglobulin G; KIM-1, kidney injury
molecule 1; MCP-1, monocyte chemotactic protein 1.
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